Dr. Aquilino Villamonte Chevalier

Theravet SA

Osteosarcoma is the most frequent bone cancer in dog associated with pain and a risk of bone fracture due to the weakening of the bone and with poor survival time at diagnosis. Treatments usually combines surgical (limited to amputation and invasive limb-sparing techniques) and non-surgical procedures. The cementoplasty with BIOCERA-VET OSTEOSARCOMA brings a new innovative and complementary minimally invasive option to non-surgical treatments to relieve pain and decrease the risk of pathological fractures.

Theravet SA

BIOCERA-VET is a line of bone substitutes with unique features in terms of ergonomics, composition and osteoconduction & osteointegration. The line is composed of 5 product references suitable as bone graft in multiples orthopedic surgical indications. The versatility of the line will be discussed from theory to pratical cases.